1
Registered trials
1
Recruiting
1
Unique sponsors
8
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Antimetabolite
2 substances
Platinum compound
2 substances
Macrolide / aminoglycoside
1 substance
Topoisomerase II inhibitor
1 substance
Alkylating agent
1 substance
Unknown / small molecule
1 substance
Phase IV:
1
Phase IV
1 trial-
RecruitingTurku University Hospital AcademicBLEOMYCIN SULFATE PH. EUR.; CAPECITABINE; CISPLATIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MESNA; OXALIPLATIN
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Turku University Hospital | Academic | 1 | Phase IV | 1 |
New trials by year
2024
1